During the history of Simcere, we have abandoned many products that had a short-term commercial value. Based on truly helping our patients, we are committed to pursuing the clinical effectiveness of drugs and making continuous efforts to improve patient accessibility. Simcere’s product portfolio comprises of over 50 products, most of which are enlisted in the National Medical Insurance and National Essential Drugs Catalogue.
Anti-Oncology
Central Nervous System
Rheumatology
Anti-infection
Cardiovascular
Others